| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3836a138f3970020f0307b159655b8d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aff6633139e8f79659a0587cc38a6c07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca939b0cccaeda64d2eb92411c4fa4ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68d721c7803d6939a53a5b8bced35d1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba6d5119a7f6ea5421c0f6f2f9f06385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7501a63838f73256fcdd4f736d9cac60 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F1-50 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-702
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C02F1-50 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-702 |
| filingDate |
2004-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_925491364e1f1047371dab27fdea161c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ad13ca8442bdf296178fd211b2c1039
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e25c21bad2bf6de13309ab36f383da5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e6895337f19e6ab9a71b229659e73b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38b4a3e26cd9313cfe345c13570dd785 |
| publicationDate |
2005-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005049045-A1 |
| titleOfInvention |
Use of alpha-cyclodextrin in the preparation of medicaments for the treatment of human or animal diseases caused by parasites belonging to the genus cryptosporidium |
| abstract |
The invention relates to the use of alpha-cyclodextrin in the preparation of medicaments for the treatment of human or animal diseases caused by parasites belonging to the genus Cryptosporidium. According to the invention, the alpha-cyclodextrin is administered orally either alone or in the form of inclusion complexes as a prophylactic and/or therapeutic agent in the treatment of animal cryptosporidiosis. The aforementioned alpha-cyclodextrin and the complexes thereof can be administered as they are or inserted in drinking water and mixed with feed, with various different formulations being used to facilitate the administration thereof. Moreover, alpha-cyclodextrin and the complexes thereof can be used to promote the elimination of infectious forms of Cryptosporidium (oocysts) in waste water and purines. |
| priorityDate |
2003-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |